论文部分内容阅读
目的探讨米非司酮联合甲氨蝶呤治疗子宫切口瘢痕妊娠的效果。方法本次实验以我院2010年1月至2011年1月所收治的40例子宫切口瘢痕妊娠患者为实验对象,随机将患者分为A、B两组,两组患者均口服米非司酮,A组患者同时经阴道超声注入甲氨蝶呤,B组患者肌内注射甲氨蝶呤,对比分析两组患者的临床疗效。结果经过治疗,A组患者治疗有效率为90%,B组患者治疗有效率为75%,A组患者临床疗效显著优于B组,两组患者的实验数据对比差异有统计学意义(P<0.05)。讨论本次实验结果表明,口服米非司酮联合甲氨蝶呤经阴道超声注入给药,治疗子宫切口瘢痕妊娠,具有较为理想的临床疗效,临床应用价值更高。
Objective To investigate the effect of mifepristone combined with methotrexate on uterine incision scar pregnancy. Methods The experiment in our hospital from January 2010 to January 2011 were treated 40 cases of uterine incision scar pregnancy patients were randomly divided into two groups A and B patients, both groups were oral mifepristone In group A, methotrexate was injected by transvaginal sonography simultaneously. In group B, methotrexate was injected intramuscularly, and the clinical efficacy was compared between the two groups. Results After treatment, the effective rate of treatment in group A was 90% and that in group B was 75%. The clinical efficacy in group A was significantly better than that in group B, and the difference between the two groups was statistically significant (P < 0.05). Discussion The results of this experiment show that oral administration of mifepristone combined with methotrexate by transvaginal ultrasound injection for the treatment of uterine incision scar pregnancy, has an ideal clinical efficacy, clinical application of higher value.